ELI LILLY & CO (LLY)
Clinical trial NCT06916078 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-01 → 2026-07-13 3. primary completion date: 2026-07-01 → 2026-07-13 4. enrollment: 33 → 30 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical